Holen Sie sich die Stockscreener-App
69.82
1.67%
1.15
Schlusskurs vom Vortag:
$68.67
Offen:
$67.68
24-Stunden-Volumen:
1.38M
Relative Volume:
1.09
Marktkapitalisierung:
$2.07B
Einnahmen:
$442.68M
Nettoeinkommen (Verlust:
$-77.81M
KGV:
-26.17
EPS:
-2.6684
Netto-Cashflow:
$-28.65M
1W Leistung:
+18.32%
1M Leistung:
+41.22%
6M Leistung:
-47.81%
1J Leistung:
-22.07%
1-Tages-Spanne:
$67.40
$71.35
1-Wochen-Bereich:
$54.82
$71.35
52-Wochen-Spanne:
$32.21
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, A, NTRA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
69.82 | 2.04B | 442.68M | -77.81M | -28.65M | -2.6684 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-05-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Alle ansehen
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
ROSEN, A LEADING NATIONAL FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
HBSS Investigates Claims Against GeneDx Holdings (WGS) in Securities Class Action Suit Following Massive Impairment Charge - marketscreener.com
HBSS Investigates Claims Against GeneDx Holdings (WGS) in - GlobeNewswire
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GeneDx Holdings Corp. Investors Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire
WGS Deadline Alert: The Gross Law Firm Reminds GeneDx - GlobeNewswire
WGS Deadline Alert: The Gross Law Firm Reminds GeneDx Holdings Corp. (WGS) Investors of Securities Class Action Deadline on August 3, 2026 - GlobeNewswire Inc.
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
GeneDx Holdings Corp. Class A Actuals & Estimates (NASDAQ:WGS) - TradingView
GeneDx Holdings (WGS) Faces Securities Class Action After 49% Dr - GuruFocus
WGS Forecast — Price Target — Prediction for 2027 - TradingView
Shareholders of GeneDx Holdings Corp. (WGS): Protect Your Rights Before August 3, 2026Contact Levi & Korsinsky - ACCESS Newswire
WGS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GeneDx Holdings Corp. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GeneDx Holdings Corp. of Class Action Lawsuit and Upcoming DeadlinesWGS - PR Newswire
INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics AcquisitionHBSS - Morningstar
GeneDx Holdings Corp (WGS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GeneDx Holdings (WGS) Faces Securities Class Action After - GlobeNewswire
Robbins LLP Urges WGS Stockholders Who Lost Money Investing in GeneDx Holdings Corp. to Contact the Firm for Information About Leading the Class Action - Barchart.com
Securities Class Action Lawsuit Filed Against GeneDx Holdings Corp. (WGS)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds GeneDx Holdings Corp. (WGS) Investors of August 3, 2026 Deadline - ACCESS Newswire
GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - TMX Newsfile
Levi & Korsinsky Urges GeneDx Holdings Corp. (WGS) Shareholders to Act Before Lead Plaintiff Deadline August 3, 2026 - ACCESS Newswire
WGS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages WGS Investors With Losses to Contact the Firm - The Globe and Mail
Did You Lose Money on GeneDx Holdings Corp. (WGS)? Levi & Korsinsky Urges Investors to Act Before August 3, 2026 - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings - GlobeNewswire
Securities Lawsuit Alert: GeneDx Holdings Corp. (WGS) InvestorsContact Levi & Korsinsky Before August 3, 2026 - ACCESS Newswire
Lost Money on GeneDx Holdings Corp. (WGS)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - PR Newswire
GENEDX HOLDINGS CORP. INVESTORS WITH LOSSES HAVE UNTIL - GlobeNewswire
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GeneDx Holdings Corp. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
symbol__ Stock Quote Price and Forecast - CNN
Morse Asset Management, Inc's GeneDx Holdings Corp(WGS) Holding History - GuruFocus
WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action LawsuitInvestors Should Contact The Gross Law Firm - Sahm
GeneDx Holdings Corp. (WGS) reports Q1 loss, lags revenue estimates - MSN
Form 4 GeneDx Holdings Corp For: 23 June By Investing.com - Investing.com South Africa
Form 4 GeneDx Holdings Corp For: 23 June - Investing.com UK
Investor Alert: Deadline Approaching to Join GeneDx Holdings Corp. (WGS) Class ActionContact Levi & Korsinsky - ACCESS Newswire
Lost Money on GeneDx Holdings Corp. (WGS)? Contact Levi & Korsinsky Before August 3, 2026 to Join Class Action - ACCESS Newswire
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GeneDx Holdings Corp. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
GeneDx Holdings Corp. (WGS) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of August 3, 2026 Deadline - ACCESS Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages GeneDx Holdings - GlobeNewswire
What a $227,000 GeneDx Insider Sale Means as Revenue Climbs 17% - Yahoo Finance
GeneDx (WGS) director Jason Ryan converts 3,576 RSUs and discloses 118,764 shares - Stock Titan
GeneDx (WGS) director Joshua Ruch exercises RSUs and receives new equity award - Stock Titan
GeneDx (WGS) director adds 3,576 shares and 4,248 new RSUs in Form 4 - Stock Titan
Keith Meister (WGS) boosts GeneDx stake via RSU exercise and new grant - Stock Titan
[Form 4] GeneDx Holdings Corp. Insider Trading Activity - Stock Titan
Eli Casdin adds shares, new RSUs at GeneDx Holdings (WGS) - Stock Titan
Piper Sandler raises GeneDx stock price target on coverage policy By Investing.com - Investing.com Australia
GeneDx Holdings shareholders approve director election and other proposals at annual meeting By Investing.com - Investing.com South Africa
GeneDx Holdings shareholders approve director election and other proposals at annual meeting - Investing.com UK
Form 8K GeneDx Holdings Corp For: 23 June - Investing.com UK
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Genedx Holdings Corp-Aktie (WGS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RUCH JOSHUA | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
33,299 |
| PFENNIGER RICHARD C JR | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
45,082 |
| Meister Keith A. | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
23,705 |
| Leproust Emily M. | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
24,852 |
| Casdin Eli | Director |
Jun 18 '26 |
Option Exercise |
0.00 |
3,576 |
0 |
24,093 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 16 '26 |
Option Exercise |
0.00 |
7,197 |
0 |
43,683 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 16 '26 |
Sale |
60.77 |
3,729 |
226,597 |
39,954 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Jun 16 '26 |
Option Exercise |
0.00 |
18,750 |
0 |
114,873 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Jun 16 '26 |
Sale |
60.77 |
10,501 |
638,104 |
104,372 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Jun 09 '26 |
Option Exercise |
0.00 |
2,462 |
0 |
37,752 |
1.76%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):